Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

Sebastian Giebel, Myriam Labopin, Jerzy Holowiecki, Boris Labar, Mieczyslaw Komarnicki, Vladimir Koza, Tamas Masszi, Martin Mistrik, Andrzej Lange, Andrzej Hellmann, Antonin Vitek, Joze Pretnar, Jiri Mayer, Piotr Rzepecki, Karel Indrak, Wieslaw Wiktor-Jedrzejczak, Jerzy Wojnar, Malgorzata Krawczyk-Kulis, Slawomira Kyrcz-Krzemien, Vanderson Rocha

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The goal of this study was to analyze results and to determine factors affecting outcome of HLA-matched hematopoetic stem cells transplantation (MRD-HSCT) for patients with acute leukemia transplanted in first complete remission in Eastern European countries. Six hundred forty HSCT were performed between 1990 and 2006 for adults with acute myeloid (n = 459) and lymphoblastic (n = 181) leukemia. Two-year leukemia-free survival (LFS), nonrelapse mortality (NRM), and relapse incidence were 58±2%, 19±2%, and 23±2%, respectively. The cumulative incidence of NRM decreased from 22±2% for patients treated between 1990 and 2002 to 15±3% for transplantations performed between 2003 and 2006 (p = 0.02), despite increasing recipient age. In a multivariate analysis, time of HSCT affected both NRM and LFS. Among other prognostic factors, the use of TBI decreased relapse incidence and increased the LFS rate. We conclude that results of MRD-HSCT for acute leukemia in Eastern Europe improved over time as a consequence of decreased NRM. The use of TBI containing regimens appears advantagous.

Original languageEnglish
Pages (from-to)1005-1013
Number of pages9
JournalAnnals of Hematology
Volume88
Issue number10
DOIs
Publication statusPublished - 2009

Keywords

  • Acute leukemia
  • Leukemia-free survival
  • Matched related donor HSCT
  • Nonrelapse mortality
  • Prognostic factors

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years'. Together they form a unique fingerprint.

  • Cite this

    Giebel, S., Labopin, M., Holowiecki, J., Labar, B., Komarnicki, M., Koza, V., Masszi, T., Mistrik, M., Lange, A., Hellmann, A., Vitek, A., Pretnar, J., Mayer, J., Rzepecki, P., Indrak, K., Wiktor-Jedrzejczak, W., Wojnar, J., Krawczyk-Kulis, M., Kyrcz-Krzemien, S., & Rocha, V. (2009). Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years. Annals of Hematology, 88(10), 1005-1013. https://doi.org/10.1007/s00277-009-0719-5